Sterling Capital Management LLC Ligand Pharmaceuticals Inc Transaction History
Sterling Capital Management LLC
- $6.45 Trillion
- Q1 2025
A detailed history of Sterling Capital Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 309 shares of LGND stock, worth $32,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
309
Previous 546
43.41%
Holding current value
$32,540
Previous $58.5 Million
44.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
279Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$302 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$216 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$108 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$95.4 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$78.4 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.78B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...